<SEC-DOCUMENT>0001364719-26-000002-index.html : 20260511
<SEC-HEADER>0001364719-26-000002.hdr.sgml : 20260511
<ACCEPTANCE-DATETIME>20260511163027
ACCESSION NUMBER:		0001364719-26-000002
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260511
FILED AS OF DATE:		20260511
DATE AS OF CHANGE:		20260511

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Kauffman Michael
		CENTRAL INDEX KEY:			0001364719
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38542
		FILM NUMBER:		26963686

	MAIL ADDRESS:	
		STREET 1:		C/O KARYOPHARM THERAPEUTICS INC.
		STREET 2:		85 WELLS AVENUE, SECOND FLOOR
		CITY:			NEWTON
		STATE:			MA
		ZIP:			02459

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kezar Life Sciences, Inc.
		CENTRAL INDEX KEY:			0001645666
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				473366145
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4000 SHORELINE COURT, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-822-5600

	MAIL ADDRESS:	
		STREET 1:		4000 SHORELINE COURT, SUITE 300
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-05112026_040513.xml
<TEXT>
Document 1 - file: form4-05112026_040513.html

Document 1 - RAW XML: form4-05112026_040513.xml

</DOCUMENT>
</SEC-DOCUMENT>